National

UK central bank raises interest rate to 3.5 pct

Dec 16, 2022

London [UK], December 16: Britain's central bank, the Bank of England (BoE) on Thursday raised its benchmark interest rate, Bank Rate, by 0.5 percentage points, to 3.5 percent, the highest since October 2008, to tackle high inflation.
At its meeting ending on Wednesday, the central bank's Monetary Policy Committee (MPC) voted 6-3 in favor of the hike. Two members preferred to maintain the rate at 3 percent, and one preferred a 0.75 percentage point rise, to 3.75 percent.
The labor market remains tight and there has been evidence of inflationary pressures in domestic prices and wages that could indicate greater persistence and thus justifies a further forceful monetary policy response, the BoE noted in a statement.
The majority of the MPC members believe that, should the economy evolve broadly in line with the committee's November projections, further rate increases may be required for a sustainable return of inflation to target.
"There are considerable uncertainties around the outlook," the BoE said. If the outlook suggests more persistent inflationary pressures, the MPC "will respond forcefully, as necessary."
Britain's twelve-month Consumer Price Index (CPI) was 10.7 percent in November, down from the 41-year high of 11.1 percent in October but still well above the BoE's 2 percent target.
Source: Xinhua

More news

Grant Thornton Bharat Acts as Exclusive Advisor to Biorad Medisys for its Fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II

New Delhi [India], May 16: Biorad Medisys Pvt. Limited ("Biorad Medisys"), a leading medical device manufacturer in India, recently completed another round of funding, raising INR 400 crore from Kotak Strategic Situations India Fund II ("KSSF II") managed by Kotak Alternate Asset Managers Ltd. (KAAML). This bolsters Biorad Medisys' financial standing and marks an exit for their existing investor, DMI Finance Group, which had previously invested in the company. Grant Thornton Bharat was the exclusive financial advisor to Biorad Medisys for the transaction.

May 16, 2024